Dermorphin Peptide: A Comprehensive Research Guide
Introduction to Dermorphin Peptide
Dermorphin is a naturally occurring heptapeptide first isolated from the skin of South American frogs (Phyllomedusa species). Unlike traditional opioids, dermorphin is highly selective for the μ-opioid receptor (MOR), making it one of the most potent natural analgesics known to science.
Due to its unique pharmacological profile, dermorphin has become a valuable tool in neuroscience, pain research, and neuropharmacology. At Wholesale China Peptides, researchers can access high-purity dermorphin peptide for controlled laboratory studies.
This 1000+ word guide covers everything researchers need to know about dermorphin peptide, including its chemical composition, mechanisms of action, research benefits, dosage protocols, and safety considerations.
What Is Dermorphin Peptide?
Dermorphin is a heptapeptide (7 amino acids) with the sequence:
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂
Key Features of Dermorphin:
✅ Highly selective for μ-opioid receptors (MOR) – More potent than morphine.
✅ Long-lasting analgesic effects – Up to 10x stronger than morphine in some studies.
✅ Resistant to enzymatic degradation – Due to D-alanine in its structure.
✅ Minimal respiratory depression – Unlike traditional opioids.
✅ Potential neuroprotective effects – Studied in stroke and brain injury models.
Dermorphin Peptide: Chemical Composition & Structure
Molecular Formula:
C₄₀H₅₀N₈O₁₀
Molecular Weight:
790.87 g/mol
Amino Acid Sequence:
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂
Key Structural Modifications:
- D-Alanine (D-Ala) – Enhances resistance to peptidases, prolonging half-life.
- Amidated C-Terminus (Ser-NH₂) – Improves receptor binding affinity.
- Two Tyrosine (Tyr) residues – Critical for μ-opioid receptor activation.
Chemical Properties:
| Property | Details |
|---|---|
| Solubility | Water-soluble (reconstitute with bacteriostatic water) |
| Storage (Lyophilized) | -20°C (stable for 2+ years) |
| Storage (Reconstituted) | 2-8°C (stable for 7-14 days) |
| Half-Life | ~2-4 hours (varies by administration route) |
| Purity | ≥98% (HPLC-verified) |
How Dermorphin Peptide Works: Mechanisms of Action
Dermorphin exerts its effects by binding to μ-opioid receptors (MOR) in the central and peripheral nervous systems. Unlike traditional opioids, dermorphin is highly selective for MOR, minimizing off-target effects.
Step-by-Step Mechanism:
- Binding to μ-Opioid Receptors (MOR) – Dermorphin binds with high affinity to MOR in the brain and spinal cord.
- Inhibition of Adenylate Cyclase – Reduces cAMP production, leading to hyperpolarization of neurons.
- Reduced Neurotransmitter Release – Inhibits the release of substance P, glutamate, and other pain-signaling molecules.
- Analgesic Effect – Blocks pain transmission at the spinal and supraspinal levels.
- Neuroprotective Effects – May reduce excitotoxicity and oxidative stress in brain injury models.
Why Dermorphin is Unique Among Opioids
- More potent than morphine (up to 10x stronger in some studies).
- Less respiratory depression (safer than traditional opioids).
- Longer-lasting effects (due to D-Ala modification).
- Minimal tolerance development (compared to morphine).
Dermorphin Peptide Benefits in Research
Dermorphin is studied for its potential therapeutic applications, including:
1. Pain Modulation & Analgesia
- Strong analgesic effects (comparable to morphine but with fewer side effects).
- Effective in neuropathic pain models (e.g., diabetic neuropathy, post-surgical pain).
- Potential for chronic pain management (studies in arthritis and cancer pain models).
2. Neuroprotection & Stroke Recovery
- Reduces excitotoxicity (protects neurons from glutamate-induced damage).
- Decreases oxidative stress (may slow neurodegeneration).
- Studied in stroke and traumatic brain injury (TBI) models.
3. Anti-Inflammatory Effects
- Modulates cytokine release (reduces pro-inflammatory markers like TNF-α and IL-6).
- Potential applications in autoimmune and inflammatory diseases.
4. Addiction & Opioid Withdrawal Research
- May help reduce opioid dependence (studies on withdrawal symptoms).
- Lower abuse potential compared to morphine.
5. Gastrointestinal & Motility Studies
- Slows gastric emptying (potential for IBS and motility disorder research).
- Reduces intestinal inflammation (studies in colitis models).
Dermorphin Peptide Dosage Protocols for Research
Since dermorphin peptide is not approved for human use, dosage guidelines are based on preclinical and clinical research models. Researchers should adjust protocols based on study objectives.
General Dosage Guidelines
| Study Type | Dosage Range | Administration Route | Frequency |
|---|---|---|---|
| Analgesia Studies | 0.1–1 mg/kg | Intravenous (IV) or Subcutaneous (SC) | Single dose or repeated (as needed) |
| Neuroprotection Studies | 0.5–2 mg/kg | Intracerebroventricular (ICV) or IV | Daily for 3–7 days |
| Anti-Inflammatory Research | 0.3–1 mg/kg | SC or IP (intraperitoneal) | Daily for 5–14 days |
| Gastrointestinal Studies | 0.1–0.5 mg/kg | SC or Oral (if modified) | Single dose or repeated |
Key Dosage Considerations
✔ Start with low doses (0.1–0.5 mg/kg) to assess tolerance.
✔ Monitor for respiratory depression (though less common than with morphine).
✔ Avoid long-term continuous use to prevent tolerance.
✔ Consider alternative administration routes (e.g., intrathecal for spinal analgesia).
Potential Side Effects & Safety Considerations
While dermorphin peptide is generally well-tolerated in research, potential side effects should be monitored:
Common Side Effects (Observed in Animal Models)
| Side Effect | Cause | Mitigation Strategy |
|---|---|---|
| Sedation | μ-opioid receptor activation | Reduce dosage if excessive |
| Constipation | Slowed gastrointestinal motility | Monitor hydration & diet |
| Respiratory depression (mild) | Central μ-opioid effects | Avoid high doses in respiratory models |
| Tolerance development | Repeated administration | Use intermittent dosing |
Long-Term Considerations
⚠ Tolerance & Dependence – Prolonged use may lead to reduced efficacy.
⚠ Withdrawal Symptoms – Sudden discontinuation may cause rebound pain or anxiety.
⚠ Cross-Tolerance with Other Opioids – May reduce effectiveness of morphine or fentanyl.
Where to Buy High-Quality Dermorphin Peptide for Research
For researchers seeking pharmaceutical-grade dermorphin peptide, Wholesale China Peptides offers:
✅ ≥98% Purity (HPLC-verified)
✅ Lyophilized for long-term stability
✅ Batch-specific COAs (Certificate of Analysis)
✅ Bulk & wholesale pricing for institutions
✅ Secure, discreet shipping worldwide
Note: Dermorphin peptide is for research use only—not for human consumption, medical treatment, or performance enhancement.
Why Dermorphin Peptide is a Game-Changer in Pain & Neuro Research
Dermorphin peptide is one of the most potent and selective μ-opioid agonists available for pain modulation, neuroprotection, and addiction research. Its unique structure, high potency, and minimal side effects make it a valuable tool for studying:
✔ Chronic pain management
✔ Neurodegenerative disease models
✔ Opioid addiction & withdrawal
✔ Inflammatory and autoimmune disorders
For high-purity dermorphin peptide at competitive prices, visit Wholesale China Peptides.
Disclaimer: This article is for educational and research purposes only. Dermorphin peptide is not approved for human use and should only be used in IRB-approved laboratory settings.
Ready to Buy Dermorphin Peptide for Research?
🔹 Visit Wholesale China Peptides
🔹 Request a COA before purchasing
🔹 Consult with a research advisor for proper dosing protocols




Reviews
There are no reviews yet.